M3 Inc banner

M3 Inc
TSE:2413

Watchlist Manager
M3 Inc Logo
M3 Inc
TSE:2413
Watchlist
Price: 1 578.5 JPY -0.03% Market Closed
Market Cap: ¥1.1T

M3 Inc
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

M3 Inc
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
M3 Inc
TSE:2413
Total Current Liabilities
¥92B
CAGR 3-Years
20%
CAGR 5-Years
18%
CAGR 10-Years
22%
S
Software Service Inc
TSE:3733
Total Current Liabilities
¥9.2B
CAGR 3-Years
9%
CAGR 5-Years
14%
CAGR 10-Years
9%
Medley Inc
TSE:4480
Total Current Liabilities
¥11.5B
CAGR 3-Years
38%
CAGR 5-Years
31%
CAGR 10-Years
N/A
CareNet Inc
TSE:2150
Total Current Liabilities
¥2.3B
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
15%
Medical Data Vision Co Ltd
TSE:3902
Total Current Liabilities
¥1.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
14%
JMDC Inc
TSE:4483
Total Current Liabilities
¥24.7B
CAGR 3-Years
30%
CAGR 5-Years
16%
CAGR 10-Years
N/A
No Stocks Found

M3 Inc
Glance View

M3 Inc. emerged from Japan in the late 1990s, rapidly morphing from a novel digital venture into a formidable player in the global medical information services arena. The company's genesis was rooted in the transformative vision of leveraging web-based platforms to bridge vast distances between healthcare professionals, providing them with timely, accurate information and resources. As the internet began revolutionizing industries, M3 Inc. seized this opportunity, focusing on creating a seamless digital environment that connected pharmaceutical companies with medical professionals. Their flagship offering, M3.com, became a pivotal platform—essentially serving as a nexus where healthcare giants could introduce their latest products and innovations to an audience of medical practitioners, facilitating informed decision-making and nurturing vital industry relationships. Reaching beyond Japanese shores, M3 Inc. strategically expanded its influence into markets in Europe, the United States, and further afield, deftly tailoring its platforms to meet diverse regulatory standards and cultural nuances. Today, its financial vitality is driven by a multifaceted business model. Primarily, M3 derives revenue from pharmaceutical companies and medical device makers who pay for advertising space and market research insights on its network, valuing the direct engagement with physicians it facilitates. Moreover, the company has smartly diversified its portfolio by incorporating online healthcare services and physician recruitment, offering a comprehensive suite of services that cater to the evolving needs of the medical community. By aligning its growth with the digital evolution of the healthcare industry, M3 Inc. continues to solidify its role as a linchpin in the health information ecosystem.

M3 Inc Intrinsic Value
LOCKED
Unlock

See Also

What is M3 Inc's Total Current Liabilities?
Total Current Liabilities
92B JPY

Based on the financial report for Dec 31, 2025, M3 Inc's Total Current Liabilities amounts to 92B JPY.

What is M3 Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
22%

Over the last year, the Total Current Liabilities growth was 15%. The average annual Total Current Liabilities growth rates for M3 Inc have been 20% over the past three years , 18% over the past five years , and 22% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett